INS and Hypoglycemia: Since the 1960s, the association among DM, cognitive dysfunction, and brain damage has been reported to be affiliated with recurrent hypoglycemia with low brain glucose concentration, secondary to pharmacological treatments for DM, especially insulin therapy in DM subjects.